Nasal septal perforation 1981–2005: Changes in etiology, gender and size by Døsen, Liv Kari & Haye, Rolf
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
BMC Ear, Nose and Throat 
Disorders
Open Access Research article
Nasal septal perforation 1981–2005: Changes in etiology, gender 
and size
Liv Kari Døsen* and Rolf Haye
Address: Department of Otolaryngology, Rikshospitalet-Radiumhospitalet HF, University of Oslo, 0027 Oslo, Norway
Email: Liv Kari Døsen* - liv.kari.dosen@rikshospitalet.no; Rolf Haye - rolf.haye@medisin.uio.no
* Corresponding author    
Abstract
Background: Septal perforation is an uncommon but very bothersome illness and treatment is
difficult particularly with large perforations. We wanted to establish the etiology and size of nasal
septal perforations in an attempt to implement preventive measures.
Methods: This is an open, prospective clinical study of patients seen at our hospital from 1981 to
2005. The clinical data of size, gender and etiology have been recorded consecutively.
Results: One hundred and ninety seven patients (100 male, 97 female) were evaluated. Between
1981 and 1995 nasal septal perforation was caused by surgery in 40 of 102 (39.2 %). In the period
1995 to and inclusive of 2005 this percentage decreased as septal resection has been replaced by
septo/septorhinoplasty. The latter was the cause for septal perforation in 14.7% in the last period.
Nasal steroid and decongestive sprays have emerged as an important cause (28.4 %) during the last
ten years particularly in females. In the first period 44 (43.1 %) and in the last 53 (55.7 %) patients
were females. There was a noticeable reduction in the number of septal perforations 15 mm or
larger in the last period.
Conclusion:  Nasal steroid and decongestive sprays are now important causes for septal
perforation. Information about this complication should be given with an advice to immediately
report increasing and bothersome crusting and bleeding. Warning of the simultaneous use of nasal
steroid and decongestive sprays should be addressed particularly to females. All patients with
symptoms of septal perforation should promptly be referred to otolaryngologists for treatment.
Background
The treatment of nasal septal perforation (SP) is sympto-
matic (local application of ointments), prosthetic, or sur-
gical. Surgery may be curative but the results are not
always satisfactory as evidenced by the many different
operative procedures that have been proposed [1-7]. Pre-
vention of SP should be an important goal. The purpose
of this study was to examine our clinical data to look for
possible changes in the pattern of etiology in order to
identify causes that may be suitable for preventive meas-
ures. We have also registered the size of the SP in order to
establish whether the size would indicate that the patients
should have been referred sooner.
Methods
We have recorded the etiology, symptoms and the size of
SP from 1981 to and inclusive of 2005. To establish the
cause of a SP we have relied on the case history, the time
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and the description of prior surgery, observations by
otolaryngologists and careful consideration of the timing
of symptoms in relation to the start of medication. For
this study we have not included patients with Wegener's
granulomatosis. In some cases we were unable to find any
specific cause for or contributing factor to the develop-
ment for the SP and have therefore labelled them
unknown. Measurement of the perforations was done
with malleable pins vertically (perpendicular to the nasal
floor) and horizontally. In 1995 we did an interim analy-
sis of patients being treated from 1981 to1995 (unpub-
lished).
There is no ethical question involved as the study is non-
experimental and only anonymous data have been used.
Results
We have seen 197 patients with symptomatic SP, 100
males with a mean age of 40.6 and 97 females with a
mean age of 41.3. In the first period there were 58 males
and 44 females, whereas in the second period there were
42 males and 53 females. The causes for SP from the cases
seen from 1981 to 1995 are compared to those observed
from 1996 to 2005 (Table 1). Causes compared to gender
are listed in Table 2. There was no predilection in brand or
delivery system of nasal steroid sprays. In a few patients
the SP occurred within three months after the start of the
application of a nasal steroid. We have only seen one
patient in whom cocaine use was the cause. Septal devia-
tion was seen in 48% of the patients. Nineteen patients in
the first period had a SP 15 mm and larger whereas only
three in the last period. Twenty nine (30 %) had a SP ten
to 14 mm in this period. There was no difference in the
size of the SP according to its cause.
Discussion
Although this study has been ongoing for 24 years the sen-
ior surgeon has been responsible for continuously regis-
tering the data during the whole study period. Thus these
data should be comparable throughout.
The main cause for SP was due to nasal operative proce-
dures in first period particularly among men as seen in
other studies [8,9]. These were, however, a less frequent
cause in the last period. The submucosal nasal septum
resection technique (Killian) has been reported to cause
SP in 17% compared to 1.3% after septo/septorhinoplasty
[10]. As the former procedure has not been performed in
Norway after 1990, this explains the reduction of surgery
as a cause. As septo/septorhinoplasty was the cause in
14.7 % of the cases in the later part of the study, we think
it is still important to emphasize the need for meticulous
care during surgery.
The higher frequency of males in the group caused by sur-
gery is probably due to a higher frequency of men under-
going nasal surgery. In 1985 nasal sprays were reported to
cause SP [11]. Although listed as a possible cause in a
review by Kridel [1], this etiology has not been recorded
in surgical studies neither before nor after 1995 [2,3,7-
9,12]. Perhaps direct questioning may uncover such
cause. The increase in nasal sprays as a cause seen in the
last period of our study may reflect the more widespread
use of nasal steroids. Of particular interest is the finding
that they are a more important cause in females than in
males as also reported by Cervin and Andersson [13]. This
was particularly evident when nasal steroid and deconges-
tive sprays were used simultaneously. As SP was seen in
patients using only inhaled steroid powder, we do not
believe that the spraying as such is the cause. The reason
for the difference in gender is not apparent. Septal devia-
tions were less frequent in females and cannot account for
Table 1: Causes of septal perforation according to time period
Time interval 1981–1995 1996–2005 Total
No (%) No (%) No
Septal resection (Killian) 22 (76) 7 (24) 29
Septo/septorhinoplasty 18 (56) 14 (44) 32
Trauma 18 (58) 13 (42) 31
Cautery 9 (47) 10 (53) 19
Nasal picking 6 (50) 6 (50) 12
Nasal steroids 1 (7) 14 (93) 15
α-adr. nasal spray 0 (0) 2 (100) 2
α-adr. + steroid sprays 0 (0) 11 (100) 11
Tamponade 1 (100) 0 (0) 1
Other 4 (67) 2 (33) 6
Unknown 23 (59) 16 (42) 39
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this difference. In this study there was a switch in the pro-
portion of males and females with a majority of females
in the last period. This tendency has not been observed in
other studies [2,8,9]. The reason for this is not evident, but
may be associated with the changing pattern in etiology.
We believe that it should be appropriate to inform
patients of SP as a complication of nasal steroid sprays
and advice them to report the occurrence of bothersome
or increasing crusting and/or bleeding as soon as possible.
These cases should promptly be referred to otolaryngolo-
gists. Early intervention may prevent the occurrence of SP.
Female patients should be warned of the danger of using
them simultaneously with decongestive nasal sprays for a
longer period.
Presently we see few of the large SPs, so many are now
amenable to surgical treatment. We would, however, like
to be able to intervene earlier. Better information to gen-
eral practitioners might ensure this.
Conclusion
Nasal septal surgery used to be the main cause for SP, par-
ticularly in men. Better surgical techniques seem to have
reduced but not eliminated this risk. Nasal steroid and
decongestive sprays are now important causes for SP.
Information about this complication should be given
with an advice to immediately report increasing and both-
ersome crusting and bleeding. Warning of the simultane-
ous use of nasal steroid and decongestive sprays should be
addressed particularly to females. All patients with symp-
toms of SP should promptly be referred to otolaryngolo-
gists for treatment.
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